Medikaloka Hermina PT (HEAL) — Capital Reinvestment Ratio
Medikaloka Hermina PT (HEAL) has a Capital Reinvestment Ratio of 1.96x as of June 2025, meaning it reinvests 2% of its operating cash flow (Rp225.37 Billion) in capital expenditures (Rp442.71 Billion). See HEAL equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medikaloka Hermina PT Capital Reinvestment Ratio (2015–2024)
This chart tracks Medikaloka Hermina PT's Capital Reinvestment Ratio across 10 annual periods. Check Medikaloka Hermina PT (HEAL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Medikaloka Hermina PT (2015–2024)
Year-by-year Capital Reinvestment Ratio for Medikaloka Hermina PT from 2015 to 2024. For live market cap and broader valuation context, see Medikaloka Hermina PT (HEAL) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.01x | Rp1.14 Trillion | Rp2.28 Trillion | ▲ +66.3% |
| 2023 | 1.21x | Rp1.32 Trillion | Rp1.59 Trillion | ▼ -46.2% |
| 2022 | 2.24x | Rp503.58 Billion | Rp1.13 Trillion | ▲ +242.9% |
| 2021 | 0.65x | Rp1.86 Trillion | Rp1.21 Trillion | ▼ -17.2% |
| 2020 | 0.79x | Rp1.13 Trillion | Rp889.65 Billion | ▼ -21.5% |
| 2019 | 1.01x | Rp572.58 Billion | Rp575.94 Billion | ▼ -68.2% |
| 2018 | 3.16x | Rp241.67 Billion | Rp764.16 Billion | ▲ +111.2% |
| 2017 | 1.50x | Rp465.08 Billion | Rp696.31 Billion | ▲ +11.3% |
| 2016 | 1.34x | Rp362.85 Billion | Rp487.92 Billion | ▼ -24.0% |
| 2015 | 1.77x | Rp255.71 Billion | Rp452.66 Billion | — |